Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Fambrough, Loretta Itri

Premium
Douglas Fambrough, a principal at Boston-based Oxford Bioscience Partners, has been appointed to the audit committee of Solexa.
 
Fambrough currently sits on the board of Sirna Therapeutics. He holds a PhD in genetics from the University of California, Berkeley.
 

 
Pharmacyclics said that board member Loretta Itri will not stand for re-election at the company’s annual meeting in December.
According to the firm, she is leaving the board in order to focus on her duties as president and chief medical officer of Genta.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.